Key result
First-in-human case series evaluates novel linear-tip pulsed field ablation catheter for combined CTI-PVI workflow.
Why the study?
Data regarding cavotricuspid isthmus ablation using pulsed field ablation remain limited despite established use of PFA for pulmonary vein isolation.
Is combined CTI and PVI ablation using the CathRx linear-tip pulsed field ablation catheter feasible and safe in humans?
Is combined CTI and PVI ablation using the CathRx linear-tip pulsed field ablation catheter feasible and safe in humans?
This abstract introduces a first-in-human evaluation of a novel linear-tip pulsed field ablation catheter for performing combined CTI and PVI.
Answers are grounded in this paper and cite their sources.
Demonstrates initial CTI ablation feasibility with novel linear-tip PFA; leaves open durability, safety, and comparative efficacy data.
Pulsed field ablation (PFA) offers excellent myocardial selectivity and a favorable safety profile. The CathRx ElectroPulse™ PFA System incorporates a novel steerable linear-tip catheter. While PFA is established for pulmonary vein isolation (PVI), data regarding cavotricuspid isthmus (CTI) ablation remain limited. We first in human experience including feasibility, and acute efficacy and safety of CTI ablation using the CathRx linear-tip catheter integrated into a combined CTI-PVI workflow.
No takes yet. Share an insight, caveat, or question.
Alexander et al. (2026) studied Arrhythmia requiring CTI and PVI ablation. CathRx ElectroPulse PFA System linear-tip catheter was evaluated on Feasibility, acute efficacy, and safety of CTI ablation. A first-in-human experience evaluated the feasibility, acute efficacy, and safety of CTI ablation using the CathRx linear-tip catheter in a combined CTI-PVI workflow, with no results reported.
Synapse has enriched 10 related papers. Consider them for comparative context: